Disclosure according to Article 5 of the EU Regulation 596/2014 and Article 2 Section (1) of the Delegated EU Regulation 2016/1052 | AlzChem

Disclosure according to Article 5 of the EU Regulation 596/2014 and Article 2 Section (1) of the Delegated EU Regulation 2016/1052

11th Interim report

In the period from May 31 up to and including June 4, 2021, a total of 4.665 shares of AlzChem Group AG were acquired as part of the share buyback program announced on February 2, 2021. The total number of shares acquired to date as part of this buyback amounts to 30.647. The acquisition was carried out by ODDO BHF Aktiengesellschaft, Frankfurt am Main/Germany via the stock exchange (XETRA) on behalf of AlzChem Group AG.

The total number of repurchased shares, the weighted average price and the aggregated volume per day were as follows:

Buyback date

Total number of shares

Weighted average price (EUR)

Aggregated volume (EUR)

31.05.2021

1.241

24,9597

30.975,00

01.06.2021

1.216

24,8342

30.198,40

02.06.2021

1.273

24,1998

30.806,40

04.06.2021

935

24,7144

23.108,00

Σ

4.665

24,6705

115.087,80

 

This information as well as the detailed information on the individual daily transactions related to the buy-back program are also published on the Company's website at https://www.alzchem.com/de/investor-relations/stock/share-buy-back in accordance with Art. 2 par. 3 sentence 2 of Delegated Regulation (EU) 2016/1052.

Trostberg, June 7, 2021

AlzChem Group AG

Sabine Sieber

Sabine Sieber

Investor Relations
T +49 8621 86-2888
F +49 8621 86-502888
ir@alzchem.com

AlzChem Group AG
Dr.-Albert-Frank-Str. 32
83308 Trostberg
Germany